GLP-1 Body Composition Monitor

The scale went down.
But what did you lose?

GLP-1 medications are transforming weight loss — but up to 39% of what patients shed is lean muscle, not fat. SarcoSense tracks exactly what kind of weight you're losing, and alerts your care team before it becomes a problem.

39%
of weight lost on semaglutide is lean muscle
400+
GLP-1 patients on the waitlist
6 mo
before sarcopenia risk becomes clinically significant
39%
of semaglutide weight loss comes from lean mass (The Lancet, 2024)
25–39%
lean mass loss range across GLP-1 clinical trials
higher muscle loss vs. diet-only restriction
65%
of lost weight regained within a year of stopping

Sources: The Lancet Diabetes & Endocrinology 2024 · NEJM STEP 1 Trial 2021 · Cell Metabolism 2025

What patients are saying

You're losing weight.
But something feels wrong.

I've lost 18kg on Wegovy and everyone says I look amazing. But I feel weaker than I did before I started. My grip is weaker, I get winded carrying groceries. The scale is down but something is off and my doctor just tells me to keep going.

r/WegovyWeightLoss · 847 upvotes

Down 30 pounds in 5 months, which sounds great on paper. But I look "skinny fat" — I've lost all the muscle tone I used to have. I don't know how much of what I've lost is actual fat versus the muscle I worked years to build.

r/Ozempic · 1.2k upvotes

Nobody warned me about this. My doctor checks my weight at every visit. She's never once mentioned body composition or lean mass. I had to figure out on my own that GLP-1 drugs can cause significant muscle loss. Why isn't this part of the standard monitoring?

r/Semaglutide · 994 upvotes

How SarcoSense works

Muscle health monitoring,
built for GLP-1 therapy.

Step 01

Log your check-in

At each clinic visit, enter your weight, body fat % from DEXA or bioimpedance, and optional biomarkers — creatinine and IGF-1. Takes under 2 minutes.

Step 02

See your lean mass trajectory

SarcoSense separates fat loss from lean mass loss and charts both over time. You'll see exactly what kind of weight you're losing — and at what rate.

Step 03

Get a personalized risk score

Each check-in recalculates your sarcopenia risk — Low, Moderate, or High — based on lean loss ratio, creatinine trend, and IGF-1 levels. Your clinician sees the same score.

JM
SR
AK
RN
+395
400+

GLP-1 patients already tracking their lean mass with SarcoSense

Clinics in 12 cities · Average patient on GLP-1: 14 weeks

The risk score

Most clinics only track weight.
We track what's inside it.

The SarcoSense risk score is calculated from lean mass loss ratio, creatinine trend, and IGF-1 — three signals that together tell a clinician whether a patient's weight loss is metabolically healthy or putting their muscle at risk.

LOW

Lean mass loss is less than 15% of total weight lost. Weight loss is predominantly fat. Continue current protocol.

MODERATE

Lean mass loss is 15–30% of total weight lost. Consider protein intake and resistance training review.

HIGH

Lean loss >30%, OR creatinine declining for 3+ visits, OR IGF-1 below 100 ng/mL. Clinician follow-up recommended.

Early access

Know what you're losing.
Before it matters.

Join 400+ GLP-1 patients getting early access. Free plan available at launch — no card required.

or

No charge until launch. Cancel anytime. Your data is never sold.

You're on the list.

We'll reach out when early access opens. In the meantime, keep tracking — your muscle health matters.